Replies to post #522237 on NorthWest Biotherapeutics Inc (NWBO)

[evanstony]

Are most bullish investors relying on the ASCO data? Yes!

When you or I start speaking for other investors....

For me and I hope others there is not a single point but a combination of things.

In my DD in 2017 for me there was a salient feature and that was LL and UCLA. I also had a high regard for LP and thought these two women could get the job done.

Over the years since then I have increased my conviction for ownership.

Where you find comedy I see tragedy.

The tragedy has been for me the time element. The delay of the last article changed my long term view of the timeline.

Very tough business and one hell of a journey... a tortuous journey for all involved.

Survival of the company has been a big win in. Challenge after challenge has been met. And I believe the journey is about to change from a promise to commercialization. That will be another set of challenges setbacks and eventual triumphs.

Focusing on the micro truths as we see them needs to be balanced with the macro truths. Lots of things have caused changes in NWBO. I for one believe the end has justified the means. Things could have been done better or worse. With the increased opportunities of the combinations with other drugs and Flashworks I really like the future here.

GLTY

[biosectinvestor]

It’s very clear, what has not happened yet. Some people spin stories to tell the story they want to believe or tell for their own reasons. Adam is a perfect example. He must tell a certain story at this point just to save face, regardless of the facts.